Li

OTC products · Product label record

Lidocaine Patch 4% drug information

LIDOCAINE 4%
Global America Group LLC · TRANSDERMAL

Product NDC: 87843-211

Join the community
CommunityExperiencesReviewsDrug database
Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameLIDOCAINE 4%
Labeler / manufacturerGlobal America Group LLC
RouteTRANSDERMAL
Drug classAmide Local Anesthetic / Antiarrhythmic
Product NDC87843-211
Label effective date2026-08-26

Official product label reference

Lidocaine Patch 4% — Global America Group LLC

This page contains 13 source sections for LIDOCAINE 4%, transdermal route. Label set 1eec782d-0e56-43d2-b842-da0ae47c5dc9, version 1.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Uses described in the label

Uses For temporary relief of pain

Purpose

Purpose Topical anesthetic
Dosage and administration — label text
Directions Adult and children 12 years of age and over : clean and dry affected area apply 1 patch at a time to affected area,not more than 3 to 4 times daily remove patch from the skin after at most 8-hour application Children under 12 years of age : consult a doctor
Warnings
Warnings (​For external use only) Do not use more than 1 patch at a time on wounds or damaged skin with a heating pad if you are allergic to any ingredients of this product When using this product use only as directed avoid contact with the eyes, mucous membranes or rashes do not bandage tightly Stop use and ask a doctor if localized skin reactions occur, such as rash, itching, redness, irritation, pain, swelling and blistering condition worsen symptoms persist for more than 7 days symptoms clear up and occur again within a few days If pregnant or breast-feeding,​ ask a health professional before use. Keep out of reach of children.​ If swallowed, get medical help or contact a Poison Control Center right away.
Unclassified section
​ Drug Facts
Active ingredient
Active ingredient Lidocaine 4%
Do not use
Do not use more than 1 patch at a time on wounds or damaged skin with a heating pad if you are allergic to any ingredients of this product
While using this medicine
When using this product use only as directed avoid contact with the eyes, mucous membranes or rashes do not bandage tightly
When to stop use and seek help
Stop use and ask a doctor if localized skin reactions occur, such as rash, itching, redness, irritation, pain, swelling and blistering condition worsen symptoms persist for more than 7 days symptoms clear up and occur again within a few days
Pregnancy or breast feeding
If pregnant or breast-feeding,​ ask a health professional before use.
Child safety
Keep out of reach of children.​ If swallowed, get medical help or contact a Poison Control Center right away.
Inactive ingredient
Inactive ingredients Glycerin, edetate disodium, tartaric acid. povidone K90. polysorbate80, propylene glycol, carboxymethylcellulose sodium, kaolin, carbomer, sodium polyacrylate,purified water. phenoxyethanol.
Storage and handling
Other information Store at room temperature 15°–30°C (59°–86°F) Avoid storing product in direct sunlight and protect product from excessive moisture. Questions or comments? Call 646-457-4800 (M-F 8AM - 5PM ET) Manufactured for: Global America Group Brooklyn, NY 11201 Made in China

Official sources and product identifiers

Substances listed: LIDOCAINE

RxNorm identifiers: 1737778

Package NDC codes

87843-211-30

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.